Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
01 Apr 2021
Historique:
pubmed: 6 2 2021
medline: 31 3 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

In this study, we aimed to assess the impact of different CT reconstruction kernels on the stability of radiomic features and the transferability between different diseases and tissue types. Three lung diseases were evaluated, Pre-treatment non-contrast enhanced CT scans from 23 NSCLC, 10 MPM and 12 SSc-ILD patients were collected retrospectively. For each patient, CT scans were reconstructed using smooth and sharp kernel in filtered back projection. The regions of interest (ROIs) were contoured on the smooth kernel-based CT and transferred to the sharp kernel-based CT. The voxels were resized to the largest voxel dimension of each cohort. In total, 1386 features were analyzed. Feature stability was assessed using the intraclass correlation coefficient. Features above the stability threshold >0.9 were considered stable. We observed a strong impact of the reconstruction method on stability of the features (at maximum 26% of the 1386 features were stable). Intensity features were the most stable followed by texture and wavelet features. The wavelet features showed a positive correlation between percentage of stable features and size of the ROI (R2 = 0.79, The robustness of radiomic features is strongly affected by different reconstruction kernels. The effect is largely influenced by the tissue type and less by the disease type. The study presents to our knowledge the most complete analysis on the impact of convolution kernel on the robustness of CT-based radiomics for four relevant tissue types in three different lung diseases. .

Identifiants

pubmed: 33544646
doi: 10.1259/bjr.20200947
pmc: PMC8010534
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20200947

Références

Med Phys. 2019 Apr;46(4):1677-1685
pubmed: 30714158
Acta Oncol. 2018 Aug;57(8):1070-1074
pubmed: 29513054
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
PLoS One. 2016 Oct 14;11(10):e0164924
pubmed: 27741289
Lung Cancer. 2019 Apr;130:108-114
pubmed: 30885330
Sci Rep. 2016 Oct 10;6:34921
pubmed: 27721474
Sci Rep. 2019 Jan 24;9(1):614
pubmed: 30679599
Radiology. 2018 Aug;288(2):407-415
pubmed: 29688159
Med Phys. 2020 Sep;47(9):4045-4053
pubmed: 32395833
J Clin Oncol. 2010 Mar 10;28(8):1380-6
pubmed: 20142596
Lancet. 2015 Sep 12;386(9998):1049-56
pubmed: 26275735
Mol Imaging Biol. 2016 Oct;18(5):788-95
pubmed: 26920355
PLoS One. 2017 Sep 21;12(9):e0178524
pubmed: 28934225
Endocrinol Metab (Seoul). 2016 Mar;31(1):38-44
pubmed: 26996421
Nat Rev Clin Oncol. 2017 Mar;14(3):169-186
pubmed: 27725679
Eur J Radiol. 2018 Mar;100:99-107
pubmed: 29496086
Invest Radiol. 2019 May;54(5):288-295
pubmed: 30570504
Medicine (Baltimore). 2019 Jul;98(29):e16423
pubmed: 31335694
Radiology. 2019 Apr;291(1):53-59
pubmed: 30694160
Med Phys. 2017 Mar;44(3):1050-1062
pubmed: 28112418
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):151-165
pubmed: 27271051
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
Stat Med. 1998 Jan 15;17(1):101-10
pubmed: 9463853
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Transl Oncol. 2014 Feb 01;7(1):88-93
pubmed: 24772211
Sci Rep. 2016 Mar 24;6:23428
pubmed: 27009765
Acta Oncol. 2010 Oct;49(7):1012-6
pubmed: 20831489
Br J Radiol. 2017 Feb;90(1070):20160665
pubmed: 27936886
Clin Chest Med. 2011 Dec;32(4):605-44
pubmed: 22054876
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1662-71
pubmed: 23857457
Clin Epidemiol. 2013 Nov 25;5:483-92
pubmed: 24348069
Q J Nucl Med Mol Imaging. 2019 Dec;63(4):355-370
pubmed: 31527578
Curr Treat Options Oncol. 2008 Jun;9(2-3):147-57
pubmed: 18709470
Lung Cancer. 2018 Jan;115:34-41
pubmed: 29290259
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Med Imaging (Bellingham). 2018 Jan;5(1):011013
pubmed: 29285518

Auteurs

Sarah Denzler (S)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Diem Vuong (D)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Marta Bogowicz (M)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Matea Pavic (M)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Thomas Frauenfelder (T)

Institute of Diagnostic and Interventional Radiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Eric Innocents Eboulet (EI)

Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.

Britta Maurer (B)

Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Janine Schniering (J)

Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Hubert Szymon Gabryś (HS)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Isabelle Schmitt-Opitz (I)

Department of Thoracic Surgery, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Miklos Pless (M)

Department of Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.

Robert Foerster (R)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Matthias Guckenberger (M)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Stephanie Tanadini-Lang (S)

Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH